AnalystsNathan TreybeckNathan Treybeck's Stock Forecasts
AnalystsNathan Treybeck
Sectors:
Analyst Ranking
Top 31%
#1517 out of 4995 analysts
Average Return
+12.83%
Win Rate
64%9 out of 14
Risk vs Reward
Poor
Good
Nathan Treybeck's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Procept Biorobotics CorpPRCT | +121.48% | $40.55 | $89.81 | 2023-12-13 - 2024-12-12 | Strong Buy |
Procept Biorobotics CorpPRCT | +77.90% | $48.60 | $86.46 | 2024-01-09 - 2025-01-08 | Strong Buy |
Procept Biorobotics CorpPRCT | +38.88% | $33.90 | $47.08 | 2023-01-12 - 2024-01-11 | Strong Buy |
Irhythm Technologies IncIRTC | +28.98% | $131.12 | $169.12 | 2025-05-02 - 2025-08-22 | Strong Buy |
Nevro CorpNVRO | +11.80% | $4.83 | $4.26 | 2024-08-07 - 2024-12-03 | Strong Sell |
Nathan Treybeck Analyst Color
Get additional color on Nathan Treybeck's coverage of popular stocks
Nathan Treybeck's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Procept Biorobotics CorpPRCT | 8 | Strong Buy | $58.00 | +40.67% | Maintains | 17 days ago |
Irhythm Technologies IncIRTC | 5 | Strong Buy | $180.00 | +6.43% | Maintains | 23 days ago |
Integer Holdings CorpITGR | 3 | Strong Buy | $132.00 | +19.37% | Maintains | a month ago |
Lemaitre Vascular IncLMAT | 1 | Hold | $95.00 | -5.31% | Initiates Coverage On | 6 months ago |
Nevro CorpNVRO | 4 | Hold | $4.00 | -31.51% | Maintains | 8 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.